🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/01/2021 66,71 68,26 66,40 68,16 +1,82% 2,79% 8.443.900
22/01/2021 66,53 67,47 66,24 66,94 -0,06% 1,85% 4.914.400
21/01/2021 67,74 67,74 66,58 66,98 -1,49% 1,71% 8.141.800
20/01/2021 67,00 68,09 66,70 67,99 +1,37% 2,07% 10.131.300
19/01/2021 64,73 68,16 64,60 67,07 +5,91% 5,50% 18.395.900
15/01/2021 62,30 63,60 62,13 63,33 +1,49% 2,36% 9.361.900
14/01/2021 61,64 63,13 61,46 62,40 +1,40% 2,71% 8.694.800
13/01/2021 61,82 62,15 61,44 61,54 -0,87% 1,15% 6.822.600
12/01/2021 62,66 62,79 61,47 62,08 -0,69% 2,11% 9.115.100
11/01/2021 63,75 64,18 62,27 62,51 -0,84% 3,00% 11.316.700
08/01/2021 62,61 63,41 62,51 63,04 +0,83% 1,44% 8.389.800
07/01/2021 61,90 63,24 61,52 62,52 +0,92% 2,78% 10.614.700
06/01/2021 59,70 62,08 59,70 61,95 +3,25% 3,99% 12.222.500
05/01/2021 60,23 60,45 59,62 60,00 -0,18% 1,38% 13.251.100
04/01/2021 58,67 60,16 57,93 60,11 +3,18% 3,80% 15.520.000
31/12/2020 56,60 58,36 56,56 58,26 +2,84% 3,18% 10.870.500
30/12/2020 57,00 57,24 56,56 56,65 -0,32% 1,19% 8.848.800
29/12/2020 56,96 57,67 56,71 56,83 -0,11% 1,69% 7.626.000
28/12/2020 57,04 57,64 56,70 56,89 -0,32% 1,65% 8.215.000
24/12/2020 57,33 57,41 56,96 57,07 -0,54% 0,78% 3.441.300
23/12/2020 56,90 57,62 56,90 57,38 +0,67% 1,27% 8.495.900
22/12/2020 58,22 58,32 56,81 57,00 -2,63% 2,59% 14.964.000
21/12/2020 58,45 58,61 57,70 58,54 -0,91% 1,56% 12.141.900
18/12/2020 59,18 59,18 58,53 59,08 +0,02% 1,10% 22.195.800
17/12/2020 58,93 59,28 58,61 59,07 +0,22% 1,14% 9.469.000
16/12/2020 59,31 59,47 58,69 58,94 -0,82% 1,32% 8.786.400
15/12/2020 59,82 60,07 59,27 59,43 -0,69% 1,34% 8.073.900
14/12/2020 60,39 60,42 59,75 59,84 -1,51% 1,11% 12.233.000
11/12/2020 60,22 60,81 60,09 60,76 +0,51% 1,20% 7.845.100
10/12/2020 60,66 60,90 60,13 60,45 -0,61% 1,27% 7.239.500